AMH and polycystic ovary syndrome: In addition to differences in the AMH assays and cutoffs values used, circulating levels of AMH tend to vary across PCOS phenotypes (Rosenfield et al., 2012; Teede et al., 2019) and it is likely that there are phenotypic variations between participants, which may account for the conflicting results.